Negative regulation of long-term synaptic potentiation

pathway activity — cross-omics
GO:1900272Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of long-term synaptic potentiation pathway is significantly associated with the protein abundance of multiple proteins, with the CCRCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are VCL, AIMP1, and MARK1, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of long-term synaptic potentiation activity versus VCL in CCRCC (Pearson r = 0.44).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CCRCCVCL →+0.511+0.070<.001<.00137
CCRCCAIMP1 →-0.117-0.070<.001<.00136
CCRCCMARK1 →+0.479+0.067.002<.00136
GBMRPL5 →-0.264-0.094<.001<.00136
COADTLN1 →+0.322+0.042<.001<.00136
COADEHD2 →+0.512+0.042.004.00236
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1900272 vs VCL — CCRCC

Per-sample scatter of Negative regulation of long-term synaptic potentiation activity vs VCL in CCRCC.

Explore this scatter interactively →

Exploration